Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Nettis MA, et al. Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial. Neuropsychopharmacology. 2021;46:939–48.
Faries D, et al. The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res. 2000;34:3–10.
Husain MI, et al. Minocycline as an adjunct for treatment-resistant depressive symptoms: a pilot randomised placebo-controlled trial. J Psychopharmacol. 2017;31:1166–75.
Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363–9.
Osimo EF, et al. Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav Immun. 2020;87:901–9.
Felger JC, et al. What does plasma CRP tell us about peripheral and central inflammation in depression? Mol Psychiatry. 2020;25:1301–11.
Chamberlain SR, et al. Treatment-resistant depression and peripheral C-reactive protein. Br J Psychiatry. 2019;214:11–9.
Author information
Authors and Affiliations
Contributions
MAN: conceptualization, methodology, writing. CMP: conceptualization, methodology, review, and editing. VM: conceptualization, review, and editing.
Corresponding author
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nettis, M.A., Pariante, C.M. & Mondelli, V. Reply to Drs Munkholm and Paludan-Müller’s comment on our paper “Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial”. Neuropsychopharmacol. 46, 1552–1553 (2021). https://doi.org/10.1038/s41386-021-01042-1
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41386-021-01042-1
